Last reviewed · How we verify
Celiac Disease
Approved treatments
Pipeline
- Group 4 in Part B and Part C · Pfizer Inc. — discontinued
- Group 3 in Part B and Part C · Pfizer Inc. — discontinued
- Group 2 in Part B and Part C · Pfizer Inc. — discontinued
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Celiac Disease patent landscape — cliff calendar, originator estates, attackable patents
- Celiac Disease treatment landscape brief
- Celiac Disease treatment updates RSS
Frequently asked questions about Celiac Disease
What new drugs are in development for Celiac Disease?
3 pipeline drugs tracked. Top candidates: Group 4 in Part B and Part C, Group 3 in Part B and Part C, Group 2 in Part B and Part C.
Related
- Treatment landscape: Celiac Disease patent cliff · Celiac Disease CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing